AMGA Foundation Launches New Initiative to Improve Evidence-Based Care for Patients with Type 2 Diabetes and Obesity

Alexandria, VA – AMGA Foundation, supported by an independent grant from Lilly, will launch a 29-month initiative focused on helping medical groups and health systems develop and implement sustainable and scalable strategies to improve the number of adult patients ages 18 to 75 with both type 2 diabetes (T2DM) and obesity who receive evidence-based care.

The Type 2 Diabetes Best Practices Learning Collaborative is designed to provide a platform for participating organizations to accelerate systemwide transformation in T2DM and obesity care through the development and implementation of quality improvement projects, best practices sharing, and peer-to-peer learning. Participating organizations will focus on achieving sustained glucose control and personalized weight management for this high-risk patient population.

“More than 90% of adults with type 2 diabetes have obesity, a dual burden that heightens the risk of cardiovascular disease and other serious complications,” said John Kennedy, MD, AMGA Foundation president and AMGA chief medical officer. “Despite clear clinical guidelines, nearly half of individuals with T2DM do not achieve recommended glycemic control, and evidence-based weight management approaches remain underutilized in routine care Through this Collaborative, we will equip healthcare organizations with the tools, data, and peer learning they need to close these care gaps and drive lasting, measurable improvements for patients.”

The following medical groups and health systems were selected to participate in the Collaborative:

• Northwest Primary Care (NWPC)
• UW Health Northern Illinois
• WellSpan Health
• UW Medicine Physicians
• Prevea Health
• Palo Alto Medical Foundation (PAMF)

Participating organizations will have access to a National Advisory Committee, a panel of subject matter and clinical experts who will guide participants in developing their quality improvement initiatives and provide educational content. Healthcare organizations will implement evidence-based interventions addressing clinical inertia, multidisciplinary care team integration, and health equity—with a focus on populations experiencing disparities in diabetes and obesity outcomes.

The Collaborative launched in early 2026.

###

About AMGA Foundation
AMGA Foundation is AMGA’s philanthropic arm that enables medical groups and other organized systems of care to consistently improve health and healthcare. AMGA Foundation serves as a catalyst, connector, and collaborator for translating the evidence of what works best in improving health and healthcare in everyday practice. Learn more at amga.org/foundation.

About AMGA
AMGA is a trade association leading the transformation of healthcare in America. Representing multispecialty medical groups and integrated systems of care, we advocate, educate, innovate, and empower our members to deliver the next level of high performance health. AMGA is the national voice promoting awareness of medical groups’ recognized excellence in the delivery of coordinated, high-quality, cost-effective care. More than 175,000 physicians practice in our member organizations, delivering care to one in three Americans. Learn more at amga.org.

References
Centers for Disease Control and Prevention. Type 2 Diabetes. 2024. cdc.gov/diabetes/about/about-type-2-diabetes.html
American Diabetes Association. Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes—2021. Diabetes Care. 2021;44(Suppl 1):S100–S110.